SUPERNUS PHARMACEUTICA
36.57
29-نوفمبر-24 13:45:00
15 متأخرة بدقائق
الأسهم
-0.42
-1.14%
نطاق اليوم
36.15 - 37.05
ISIN
N/A
المصدر
NASDAQ
-
Supernus Announces Second Quarter 2021 Financial Results
04 أغسطس 2021 16:09:33 بحسب Nasdaq GlobeNewswire
-
Supernus to Host Second Quarter 2021 Financial Results Conference Call
22 يوليو 2021 16:37:21 بحسب Nasdaq GlobeNewswire
-
Supernus to Present at Jefferies Virtual Healthcare Conference
25 مايو 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
24 مايو 2021 08:30:00 بحسب Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2021 Financial Results
05 مايو 2021 16:01:00 بحسب Nasdaq GlobeNewswire
-
Supernus Announces Paragraph IV ANDA Filing for XADAGO®
04 مايو 2021 20:49:10 بحسب Nasdaq GlobeNewswire
-
Supernus to Host First Quarter 2021 Financial Results Conference Call
27 أبريل 2021 17:44:01 بحسب Nasdaq GlobeNewswire
-
Supernus Announces FDA Approval of Qelbree™ (SPN-812) for the Treatment of ADHD
02 أبريل 2021 16:58:32 بحسب Nasdaq GlobeNewswire
-
Supernus to Present at Cowen Healthcare Conference
26 فبراير 2021 09:00:00 بحسب Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2020 Financial Results
25 فبراير 2021 16:00:00 بحسب Nasdaq GlobeNewswire
-
Supernus to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call
23 فبراير 2021 09:00:00 بحسب Nasdaq GlobeNewswire
-
Supernus Resubmits New Drug Application for SPN-812 for the Treatment of ADHD in Pediatric Patients
08 فبراير 2021 09:00:00 بحسب Nasdaq GlobeNewswire
-
Supernus to Present at J.P. Morgan 39th Annual Healthcare Conference
06 يناير 2021 17:29:08 بحسب Nasdaq GlobeNewswire